Skip to main content
All lobbying clients

MERCK & CO INC

Lobbying client · New Jersey · filed 2025 to 2026

$22,480,000 Reported spend
67 Filings counted
11 Outside firms hired
27 Bills named

Spend is reported income plus in-house expenses across 67 filings. 1 further filing for this client was restated by a later amendment and is left out of every total here. The LDA keeps a separate client record for every registrant that files for a client, so this page adds up 12 records, one per registrant listed below. Records are combined when the client name matches once case, punctuation and endings such as Inc. or LLC are set aside; for a city, county or port the state has to match as well. These filings have also been reported as MERCK & CO. INC., MERCK & CO., INC, MERCK & CO., INC., MERCK & COMPANY, INC.

 Who filed for this client 12

Spend per registrant: fees an outside firm reported, or the costs the client reported for lobbying in-house. The rows add up to the total above.

 Bills named in these filings 27
  • H.R. 1
    One Big Beautiful Bill Act
    20 filings
  • H.R. 1492
    To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and bi…
    11 filings
  • H.R. 4299
    Protecting Patient Access to Cancer and Complex Therapies Act
    8 filings
  • S. 891
    Bipartisan Health Care Act
    8 filings
  • S. 2076
    PASTEUR Act of 2021
    7 filings
  • S. 1339
    Pharmacy Benefit Manager Reform Act
    6 filings
  • S. 864
    HELP Copays Act
    6 filings
  • H.R. 946
    ORPHAN Cures Act
    5 filings
  • H.R. 1968
    Full-Year Continuing Appropriations and Extensions Act, 2025
    4 filings
  • S. 1862
    ORPHAN Cures Act
    4 filings
  • H.R. 1503
    Prescription Information Modernization Act of 2023
    2 filings
  • S. 2916
    Prescription Information Modernization Act of 2023
    2 filings
  • H. Con. Res. 14
    Establishing the congressional budget for the United States Government for fiscal year 2025 and setting forth…
    2 filings
  • H.R. 1244
    Reducing Drug Prices for Seniors Act
    2 filings
  • H.R. 3838
    Streamlining Procurement for Effective Execution and Delivery and National Defense Authorization Act for Fisc…
    2 filings
  • H.R. 8800
    National Defense Authorization Act for Fiscal Year 2027
    2 filings
  • H.R. 8857
    Next GEN Act of 2026
    2 filings
  • S. 1040
    Drug Competition Enhancement Act
    2 filings
  • S. 2296
    National Defense Authorization Act for Fiscal Year 2026
    2 filings
  • S. 4784
    National Defense Authorization Act for Fiscal Year 2027
    2 filings
  • H.R. 8467
    Farm, Food, and National Security Act of 2024
    1 filing
  • H.R. 10628
    Biosimilars Access and Affordability Act
    1 filing
  • H.R. 1672
    Maintaining Investments in New Innovation Act
    1 filing
  • H.R. 2484
    Seniors’ Access to Critical Medications Act of 2025
    1 filing
  • H.R. 5376
    Impacts and Outcomes for Health Career Training Act
    1 filing
  • S. 1163
    Rural Veterinary Workforce Act
    1 filing
  • S. 5571
    Biosimilars Access and Affordability Act
    1 filing
 Reported by year 2 years
  • 2026 $9,900,000 26 filings
  • 2025 $12,580,000 41 filings
 Issues lobbied 9

The count is how many filings named that issue area. A filing reports one lump figure covering every issue on it, so the money above cannot be split between them.

 Agencies and chambers lobbied 13
  • HOUSE OF REPRESENTATIVES 60
  • SENATE 53
  • Centers For Medicare and Medicaid Services (CMS) 11
  • Executive Office of the President (EOP) 11
  • Food & Drug Administration (FDA) 7
  • Health & Human Services, Dept of (HHS) 7
  • Office of Management & Budget (OMB) 7
  • White House Office 7
  • Centers For Disease Control & Prevention (CDC) 5
  • U.S. Trade Representative (USTR) 3
  • Commerce, Dept of (DOC) 2
  • Agriculture, Dept of (USDA) 1
  • Bureau of Industry and Security (BIS) 1
 Recent filings 68 total
Q3 report
MERCK & CO, INC.
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $2,390,000 expenses · posted Oct 20, 2026
View →
Q3 report
WILLIAMS AND JENSEN, PLLC
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $50,000 income · posted Oct 20, 2026
View →
Q3 report
AVENUE SOLUTIONS
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $50,000 income · posted Oct 20, 2026
View →
Q3 report
W STRATEGIES, LLC
3rd Quarter 2026 (July 1 - Sep 30) · House · $50,000 income · posted Oct 19, 2026
View →
Q3 report
THE NICKLES GROUP, LLC
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $70,000 income · posted Oct 19, 2026
View →
Q3 report
TIBER CREEK GROUP
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $50,000 income · posted Oct 19, 2026
View →
Q3 report
TODD STRATEGY GROUP
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $50,000 income · posted Oct 19, 2026
View →
Q3 report
CROSSROADS STRATEGIES, LLC
3rd Quarter 2026 (July 1 - Sep 30) · House · Senate · $40,000 income · posted Oct 17, 2026
View →
Q3 report
THE WASHINGTON TAX & PUBLIC POLICY GROUP
3rd Quarter 2026 (July 1 - Sep 30) · $10,000 income · posted Oct 16, 2026
View →
Registration
THE WASHINGTON TAX & PUBLIC POLICY GROUP
3rd Quarter 2026 (July 1 - Sep 30) · posted Oct 8, 2026
View →
Q2 report
TODD STRATEGY GROUP
2nd Quarter 2026 (Apr 1 - June 30) · House · Senate · $50,000 income · posted Jul 20, 2026
View →
Q2 report
WILLIAMS AND JENSEN, PLLC
2nd Quarter 2026 (Apr 1 - June 30) · House · Senate · $50,000 income · posted Jul 20, 2026
View →
Q2 report
W STRATEGIES, LLC
2nd Quarter 2026 (Apr 1 - June 30) · House · $50,000 income · posted Jul 20, 2026
View →
Q2 report
AVENUE SOLUTIONS
2nd Quarter 2026 (Apr 1 - June 30) · House · Senate · $50,000 income · posted Jul 20, 2026
View →
Q2 report
MERCK & CO, INC.
2nd Quarter 2026 (Apr 1 - June 30) · House · Senate · $2,270,000 expenses · posted Jul 20, 2026
View →
Q2 report
THE NICKLES GROUP, LLC
2nd Quarter 2026 (Apr 1 - June 30) · House · Senate · $70,000 income · posted Jul 20, 2026
View →
Q2 report
TIBER CREEK GROUP
2nd Quarter 2026 (Apr 1 - June 30) · House · Senate · $50,000 income · posted Jul 19, 2026
View →
Q2 report
CROSSROADS STRATEGIES, LLC
2nd Quarter 2026 (Apr 1 - June 30) · House · Senate · $40,000 income · posted Jul 17, 2026
View →
Q1 report
AVENUE SOLUTIONS
1st Quarter 2026 (Jan 1 - Mar 31) · House · Senate · $50,000 income · posted Apr 20, 2026
View →
Q1 report
CROSSROADS STRATEGIES, LLC
1st Quarter 2026 (Jan 1 - Mar 31) · House · Senate · $40,000 income · posted Apr 20, 2026
View →

Showing the 20 most recent of 68 filings. Search the explorer for "MERCK & CO INC".

Filings through , the newest posted date on this record. Source: federal Lobbying Disclosure Act filings, synced daily. Money is self-reported by the filer and often rounded. Lobbying is legal, disclosed activity.

Report a problem